Novo Nordisk meeting sponsorship criticised as ‘Christmas meal’ impression: breaches of Clauses 15.2 and 19.1 (AUTH/2470/1/12)

📅 2012 | 🖉 Dr Anzal Qurbain
📊

Key facts

CaseAUTH/2470/1/12
PartiesAnonymous complainant v Novo Nordisk
IssueArrangements for a meeting (restaurant event perceived as Christmas social meal)
Applicable Code year2011
Event timing15 December 2011 (mid-December 2011)
VenueLocal restaurant; meeting area without a door (privacy questioned)
Attendees26 attended (30 meal choices submitted; 4 paid for non-attendees); included clinicians, nurses, administrative staff; one GP with special interest in diabetes
CostsTotal £953.15 (food & drinks); Novo Nordisk paid £450; cost per head incl drinks £32.81; bill paid 10.42pm
Key evidenceEmail invitation titled “Christmas at [named restaurant]” referencing “Xmas meal” and “The meal… late”; limited written correspondence; no sponsorship declaration on materials
Panel decisionBreach Clauses 19.1, 15.2, and 2 (Clause 2 later appealed)
Appeal outcomeClause 19.1 breach upheld; Clause 2 overturned (No breach); Clause 15.2 not appealed
SanctionsUndertaking received; additional sanctions not stated
Complaint received3 January 2012
Case completed15 May 2012

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • An anonymous, non-contactable health professional alleged Novo Nordisk (and Sanofi) paid for what was “clearly a Christmas party” for a local diabetes team (clinicians, nurses and administrative staff) in mid-December 2011 at a restaurant.
  • The event was organised by the clinical lead consultant with company representatives; the complainant said the “supposed agenda did not materialise”, there was a partition to separate representative stands, and a representative from another company arrived then left.
  • Novo Nordisk said it was an evening hospital departmental meeting to launch an inpatient diabetes service and discuss future plans; two local consultants presented and discussion continued over dinner.
  • Key documentary issue: only a brief email exchange existed. The invitation email subject line was “FW: Christmas at [named restaurant] 15th of December” and referred to an “Xmas meal” and “The meal: 07.30 – late”, creating a strong social impression.
  • The representative reminded the organiser about needing a private room and 1½ hours of presentation/discussion to comply with the Code, and stated wine/beer/soft drinks could be paid for in moderation (spirits individually).
  • The agenda (as provided) showed a 7pm start, two short presentations (20 mins and 15 mins) and Q&A ending 7.50pm; Novo Nordisk said IT delays meant it started 7.20pm and finished 8.40pm with discussion over dinner.
  • Venue/privacy concerns: the “meeting room” did not have a door; a Boehringer Ingelheim representative reportedly left due to this. Novo Nordisk said the area was private and not visible/audible from public areas.
  • Costs: total food and drinks £953.15 split between Novo Nordisk (£450) and Sanofi (£503.15). Cost per head (including drinks) £32.81; bill paid at 10.42pm. Four meals were paid for non-attendees.
  • No meeting materials before the Panel contained a declaration of Novo Nordisk’s sponsorship.
⚖️

Outcome

  • Breach of Clause 19.1 (Meetings and hospitality) ruled by the Panel and upheld on appeal.
  • Breach of Clause 15.2 (High standards) ruled by the Panel (not appealed).
  • Clause 2 (Discredit) was ruled breached by the Panel but overturned on appeal: No breach of Clause 2 on balance in light of the educational content.
  • Clause 9.1 allegation was considered covered by the ruling under Clause 15.2.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training